Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Hypoxia 4 Uterine Cervical Neoplasms 3 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Hypoxic Tumours 1 Head and Neck Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Adenosquamous 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Indocyanine Green 7 Lymph Node Excision 6 Surgical Procedures, Operative 5 Radiotherapy, Intensity-Modulated 4 Radiotherapy 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Cisplatin 4 Specimen Handling 3 gadofosveset trisodium 2 Technetium 2 TP protocol 2 Sentinel Lymph Node Biopsy 2 Radiation Dose Hypofractionation 2 Nivolumab 2 Ipilimumab 2 Electroporation 2 Conversion to Open Surgery 2 Control Groups 2 Chemotherapy, Adjuvant 2 Chemoradiotherapy 2 Artificial Intelligence 2 tislelizumab 1 sarcolipin 1 radium Ra 223 dichloride 1 peposertib 1 pembrolizumab 1 lncRNA LNMAT1, human 1 gewf solution 1 fluoroazomycin arabinoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphatic Metastasis × fluoroazomycin arabinoside × Clear all

NCT03955393 2020-12-22

FAZA

IRCCS San Raffaele

Carcinoma, Renal Cell, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡